Longaeva Partners’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Longaeva Partners's CYTK Position: Q3 2026 in Review
Longaeva Partners opened a new position in Cytokinetics (CYTK) in Q3 2026: 361,821 shares worth $23.8M. The stake represents 0.49% of the portfolio and ranks #42 among its holdings.
472 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Longaeva Partners held 361,821 shares of Cytokinetics worth $23.8M as of Q3 2026.
- Cytokinetics was a new Longaeva Partners position in Q3 2026.
- Cytokinetics made up 0.49% of Longaeva Partners's portfolio in Q3 2026, its #42 holding.
- 472 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.